Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Marchioli

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Blood|July 5, 2011
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosisPaola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi, et al.
Leukemia & Lymphoma|January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
Blood|June 26, 2014
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Judith D Goldberg, Luis Isola, et al.
The New England Journal of Medicine|December 11, 2012
Cardiovascular events and intensity of treatment in polycythemia veraRoberto Marchioli, Guido Finazzi, Giorgina Specchia, et al.
European Heart Journal|March 25, 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsDavid Preiss, Ross T Campbell, Heather M Murray, et al.
Lancet (London, England)|February 20, 2010
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsNaveed Sattar, David Preiss, Heather M Murray, et al.
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Lancet (London, England)|September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Blood|July 5, 2011
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosisPaola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi, et al.
Leukemia & Lymphoma|January 8, 2015
Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O Hexner, John Mascarenhas, Josef Prchal, et al.
Blood|June 26, 2014
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosisDamiano Rondelli, Judith D Goldberg, Luis Isola, et al.
The New England Journal of Medicine|December 11, 2012
Cardiovascular events and intensity of treatment in polycythemia veraRoberto Marchioli, Guido Finazzi, Giorgina Specchia, et al.
European Heart Journal|March 25, 2015
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsDavid Preiss, Ross T Campbell, Heather M Murray, et al.
Lancet (London, England)|February 20, 2010
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trialsNaveed Sattar, David Preiss, Heather M Murray, et al.
Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.
Lancet (London, England)|September 29, 2014
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsDaniel I Swerdlow, David Preiss, Karoline B Kuchenbaecker, et al.
Pageof 11